Intellectual Property India Publishes Patent Application for Cd33 Antibodies, Cd33/Vd2 Multispecific Antibodies And Uses Thereof

MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081712 A) filed by Janssen Biotech, Inc. on July 02, 2026, for Cd33 Antibodies, Cd33/Vd2 Multispecific Antibodies And Uses Thereof.

Inventors include Elashkar, Sara Mohamed A; Kallal, Lorena A; Jacobs, Steven A.; Philippar, Ulrike; Doonan, Patrick John Application Number; Parren, Paul Willem Henri Ida; Merat, Sabrina Julia Louisa; Roovers, Robertus Cornelis Number; Van Der Vliet, Johannes Jelle; and Van Helden, Paula Maria Wilhelmina.

The application for the patent was published on August 28, 2026, under issue no. 35/2026.

Abstract: CD33 antibodies, and antigen-binding fragments thereof, and CD33/Vd2 multispecific antibodies, or antigen- bindi...